Rheumatoid Arthrities: Etiology Pathophysiology and Modern Treatments
DOI:
https://doi.org/10.31033/ijrasb.9.3.7Keywords:
Rheumatoid arthritis, Pathogenesis, Etiology, Modern treatmentAbstract
Rheumatoid arthritis (RA) is an autoimmune disease that affects the joints. Age, gender, genetics, and environmental exposure are all factors (cigarette smoking, air pollutants, and occupational). If untreated, felty syndrome, rheumatoid vasculitis, and irreversible joint damage might occur, necessitating splenectomy. Because there is no cure for RA, treatment seeks to reduce pain and prevent further damage.
To develop effective RA treatments, researchers must first understand how the disease advances in people and how pathogenic pathways influence this progression. Modern pharmacologic therapy have made tremendous progress in obtaining illness remission without joint deformity (including conventional and biological treatments as well as novel potential small-molecule disease-modifying drugs). Despite this, many RA patients do not respond well to conventional treatments, necessitating the development of novel drugs. This comprehensive review of current advancements covers RA causation, disease-modifying drugs, and prospective RA therapeutics. This section summarises the various RA-related therapies available in the past and now.
Downloads
References
Alamanos Y, Voulgari PV, Drosos AA. Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: a systematic review. Semin Arthritis Rheum. 2006 Dec;36((3)):182–8.
Chopra A, Abdel-Nasser A. Epidemiology of rheumatic musculoskeletal disorders in the developing world. Best Pract Res Clin Rheumatol. 2008 Aug;22(4):583–604.
McGonagle D, Hermann KG, Tan AL. Differentiation between osteoarthritis and psoriatic arthritis: implications for pathogenesis and treatment in the biologic therapy era. Rheumatology (Oxford) 2015 Jan;54((1)):29–38.
Piyarulli D, Koolaee RM. A 22-Year-Old Female With Joint Pain. In: Piyarulli D, Koolaee RM, editors. Medicine Morning Report: Beyond the Pearls. Cambridge: Elsevier; 2016. pp. pp. 65–77.
C G Awuchi; I O Amagwula, P Priya, R Kumar, U Yezdani, M G Khan. Aflatoxins In Foods And Feeds: A Review On Health Implications, Detection, And Control. Bull. Env. Pharmacol. Life Sci., Vol 9[9] August 2020 : 149-155
Smolen JS, Aletaha D, Barton A, Burmester GR, Emery P, Firestein GS, et al. Rheumatoid arthritis. Nat Rev Dis Primers. 2018 Feb;4:18001.
Ong CK, Lirk P, Tan CH, Seymour RA. An evidence-based update on nonsteroidal anti-inflammatory drugs. Clin Med Res. 2007 Mar;5((1)):19–34.
Combe B, Landewe R, Daien CI, Hua C, Aletaha D, Álvaro-Gracia JM, et al. 2016 update of the EULAR recommendations for the management of early arthritis. Ann Rheum Dis. 2017 Jun;76(6):948–59.
Roshan, K. (2020). Priya damwani, Shivam kumar, Adarsh suman, Suthar Usha. An overview on health benefits and risk factor associated with coffee. International Journal Research and Analytical Review, 7(2), 237-249.
Whittle SL, Colebatch AN, Buchbinder R, Edwards CJ, Adams K, Englbrecht M, et al. Multinational evidence-based recommendations for pain management by pharmacotherapy in inflammatory arthritis: integrating systematic literature research and expert opinion of a broad panel of rheumatologists in the 3e Initiative. Rheumatology (Oxford) 2012 Aug;51((8)):1416–
Richards BL, Whittle SL, van der Heijde DM, Buchbinder R. The efficacy and safety of antidepressants in inflammatory arthritis: a Cochrane systematic review. J Rheumatol Suppl. 2012 Sep;90((0)):21–7.
Sahana, S. (2020). Roshan kumar, Sourav nag, Reshmi paul, Nilayan guha, Indranil Chatterjee. A Review on Alzheimer disease and future prospects. World Journal of Pharmacy and Pharmaceutical science, 9(9), 1276-1285.
Sahana, S. (2020). Purabi saha, Roshan kumar, Pradipta das, Indranil Chatterjee, Prasit Roy, Sk Abdur Rahamat. A Review of the 2019 Corona virus (COVID-19) World Journal of Pharmacy and Pharmaceutical science, 9(9), 2367-2381.
Tian H, Cronstein BN. Understanding the mechanisms of action of methotrexate: implications for the treatment of rheumatoid arthritis. Bull NYU Hosp Jt Dis. 2007;65((3)):168–73.
Daien CI, Hua C, Combe B, Landewe R. Non-pharmacological and pharmacological interventions in patients with early arthritis: a systematic literature review informing the 2016 update of EULAR recommendations for the management of early arthritis. RMD Open. 2017 Jan;3((1)):e000404.
Silva JC, Mariz HA, Rocha LF, Jr, Oliveira PS, Dantas AT, Duarte AL, et al. Hydroxychloroquine decreases Th17-related cytokines in systemic lupus erythematosus and rheumatoid arthritis patients. Clinics (São Paulo) 2013 Jun;68((6)):766–71.
Roshan Kumar, Purabi Saha, Priyatosh Pathak, Ramayani Mukherjee4 , Abhishek Kumar6 , Rakesh Kumar Arya. EVOLUTION OF TOLBUTAMIDE IN THE TREATMENT OF DIABETES MELLITUS. Jour. of Med. P’ceutical & Alli. Sci. V 9-I 6, 956. November-December 2020, P-2605-2609.
Sailaja AK. An overall review on rheumatoid arthritis. Journal of Current Pharma Research. 2014;4:1138–43.
Kumar P, Banik S. Pharmacotherapy options in rheumatoid arthritis. Clin Med Insights Arthritis Musculoskelet Disord. 2013 Aug;6:35–43.
Fox RI, Herrmann ML, Frangou CG, Wahl GM, Morris RE, Kirschbaum BJ. How does leflunomide modulate the immune response in rheumatoid arthritis? BioDrugs. 1999 Oct;12((4)):301–15.
Gibofsky A. Combination therapy for rheumatoid arthritis in the era of biologicals. HSS J. 2006 Feb;2((1)):30–41.
Kumar, R., & Dubey, A. PHYTOCHEMICAL INVESTICATION AND HEPTOPROTECTIVE EVALUTION ACACIA RUBICA EXTRACT ISONIZED AND PARACETAMOL INDUSED ANIMAL TOXICITY. Turkish Journal of Physiotherapy and Rehabilitation, 32, 3.
den Broeder AA, van Herwaarden N, van den Bemt BJ. Therapeutic drug monitoring of biologicals in rheumatoid arthritis: a disconnect between beliefs and facts. Curr Opin Rheumatol. 2018 May;30((3)):266–75.
kumar, saha, shrestha sarkar, nikita rawat , amit prakash, "a review on novel drug delivery system", ijrar - international journal of research and analytical reviews (ijrar), e-issn 2348-1269, p- issn 2349-5138, volume.8, issue 1, page no pp.183-199, january 2021, available at : http://www.ijrar.org/ijrarjfm1024.pdf
Dubey, A. (2021). Effect of isoproterenol and thyroxine in herbal drug used as cardiac hypertrophy. Journal of Cardiovascular Disease Research.
Gay RD, Clarke AW, Elgundi Z, Domagala T, Simpson RJ, Le NB, et al. Anti-TNFα domain antibody construct CEP-37247: full antibody functionality at half the size. MAbs. 2010 Nov-Dec;2((6)):625–38.
Lis K, Kuzawińska O, Bałkowiec-Iskra E. Tumor necrosis factor inhibitors - state of knowledge. Arch Med Sci. 2014 Dec;10((6)):1175–85.
Perpétuo IP, Caetano-Lopes J, Rodrigues AM, Campanilho-Marques R, Ponte C, Canhão H, et al. Effect of Tumor Necrosis Factor Inhibitor Therapy on Osteoclasts Precursors in Rheumatoid Arthritis. BioMed Res Int. 2017;2017:2690402.
Mann DL. Innate immunity and the failing heart: the cytokine hypothesis revisited. Circ Res. 2015 Mar;116((7)):1254–68.
Curtis JR, Singh JA. Use of biologics in rheumatoid arthritis: current and emerging paradigms of care. Clin Ther. 2011 Jun;33((6)):679–707.
Mok CC. Rituximab for the treatment of rheumatoid arthritis: an update. Drug Des Devel Ther. 2013 Dec;8:87–100.
Emer JJ, Claire W. Rituximab: a review of dermatological applications. J Clin Aesthet Dermatol. 2009 May;2((5)):29–37.
Rosman Z, Shoenfeld Y, Zandman-Goddard G. Biologic therapy for autoimmune diseases: an update. BMC Med. 2013 Apr;11((1)):88.
Gómez-Gómez GJ, Masedo Á, Yela C, Martínez-Montiel MP, Casís B. Current stage in inflammatory bowel disease: what is next? World J Gastroenterol. 2015 Oct;21((40)):11282–303.
Hodge JA, Kawabata TT, Krishnaswami S, Clark JD, Telliez JB, Dowty ME, et al. The mechanism of action of tofacitinib - an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis. Clin Exp Rheumatol. 2016 Mar-Apr;34((2)):318–28.
Cada DJ, Demaris K, Levien TL, Baker DE. Tofacitinib. Hosp Pharm. 2013 May;48((5)):413–24.
Nyarko, R., Prakash, A., Kumar, N., Saha, P., & Kumar, R. (2021). Tuberculosis a globalized disease: Review. Asian Journal of Pharmaceutical Research and Development, 9(1), 198-201. https://doi.org/https://doi.org/10.22270/ajprd.v9i1.898
SHAFQAT ZAIDI, RAVINDER Kr. MEHRA, Dr. SACHIN TYAGI, ROSHAN KUMAR ANUBHAV DUBEY. (2021). Effect of Kalahari Cactus Extract on Appetitte , Body Weight And Lipid Profile In Cafeteria Diet Induced Obesity In Experimental Animal. Annals of the Romanian Society for Cell Biology, 25(6), 13976–13987.
Louie GH, Ward MM. Changes in the rates of joint surgery among patients with rheumatoid arthritis in California, 1983-2007. Ann Rheum Dis. 2010 May;69((5)):868–71.
Chung KC, Pushman AG. Current concepts in the management of the rheumatoid hand. J Hand Surg Am. 2011 Apr;36((4)):736–47.
Knut L. Radiosynovectomy in the therapeutic management of arthritis. World J Nucl Med. 2015 Jan-Apr;14((1)):10–5.
Puddu G, Cipolla M, Cerullo G, Franco V, Giannì E. Which osteotomy for a valgus knee? Int Orthop. 2010 Feb;34((2)):239–47.
Nyarko, R. O., Saha, P., Kumar, R., Kahwa, I., Boateng, E. A., Boateng, P. O., Christian, A., & Bertram, A. (2021). Role of Cytokines and Vaccines in Break through COVID 19 Infections. Journal of Pharmaceutical Research International, 33(60B), 2544-2549. https://doi.org/10.9734/jpri/2021/v33i60B34912
Brooks F, Hariharan K. The rheumatoid forefoot. Curr Rev Musculoskelet Med. 2013 Dec;6((4)):320–7.
Rheumatic surgery-overview/Surgical treatment-general opinions. Acta Orthop Scand. 2000;71((sup294 Suppl 294)):8–14.
Pajarinen J, Lin TH, Sato T, Yao Z, Goodman SB. Interaction of Materials and Biology in Total Joint Replacement - Successes, Challenges and Future Directions. J Mater Chem B Mater Biol Med. 2014 Nov;2((41)):7094–108.
Halstead JA, Stoten S. Orthopedic Nursing: Caring for Patients with Musculoskeletal Disorders. Bridgewater: Western Schools; 2010.
Escott-Stump S. Nutrition and Diagnosis-Related Care. Philadelphia: Lippincott Williams & Wilkins; 2011.
Bind, A., Das, S., Singh, V. D., Kumar, R., Chourasia, A., & Saha, P. NATURAL BIOACTIVES FOR THE POTENTIAL MANAGEMENT OF GASTRIC ULCERATION. Turkish Journal of Physiotherapy and Rehabilitation, 32, 3.
Cooney JK, Law RJ, Matschke V, Lemmey AB, Moore JP, Ahmad Y, et al. Benefits of exercise in rheumatoid arthritis. J Aging Res. 2011 Feb;2011:681640.
Zitnay JL, Li Y, Qin Z, San BH, Depalle B, Reese SP, et al. Molecular level detection and localization of mechanical damage in collagen enabled by collagen hybridizing peptides. Nat Commun. 2017 Mar;8:14913.
Burska AN, Roget K, Blits M, Soto Gomez L, van de Loo F, Hazelwood LD, et al. Gene expression analysis in RA: towards personalized medicine. Pharmacogenomics J. 2014 Apr;14((2)):93–106.
Sahana, S., Kumar, R., Nag, S., Paul, R., Chatterjee, I., & Guha, N. (2020). A REVIEW ON ALZHEIMER DISEASE AND FUTURE PROSPECTS.
Kumar, R., Saha, P., Kumar, Y., Sahana, S., Dubey, A., & Prakash, O. (2020). A REVIEW ON DIABETES MELLITUS: TYPE1 & TYPE2.
González-Álvaro I, Ortiz AM, Seoane IV, García-Vicuña R, Martínez C, Gomariz RP. Biomarkers predicting a need for intensive treatment in patients with early arthritis. Curr Pharm Des. 2015;21((2)):170–81.
Deane K.D., Demoruelle M.K., Kelmenson L.B., Kuhn K.A., Norris J.M., Holers V.M. Genetic and environmental risk factors for rheumatoid arthritis. Best Pr. Res. Clin. Rheumatol. 2017;31:3–18.
McGraw W.T., Potempa J., Farley D., Travis J. Purification, Characterization, and Sequence Analysis of a Potential Virulence Factor from Porphyromonas gingivalis, Peptidylarginine Deiminase. Infect. Immun. 1999;67:3248–3256.
Tan E.M., Smolen J.S. Historical observations contributing insights on etiopathogenesis of rheumatoid arthritis and role of rheumatoid factor. J. Exp. Med. 2016;213:1937–1950.
Wegner N., Wait R., Sroka A., Eick S., Nguyen K.-A., Lundberg K., Kinloch A.J., Culshaw S., Potempa J., Venables P.J. Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and α-enolase: Implications for autoimmunity in rheumatoid arthritis. Arthritis Rheum. 2010;62:2662–2672.
Saha, P., Kumar, R., Nyarko, R. O., Kahwa, I., & Owusu, P. (2021). HERBAL SECONDARY METABOLITE FOR GASTRO-PROTECTIVE ULCER ACTIVITY WITH API STRUCTURES.
Tiwana H., Wilson C., Alvarez A., Abuknesha R., Bansal S., Ebringer A. Cross-Reactivity between the Rheumatoid Arthritis-Associated Motif EQKRAA and Structurally Related Sequences Found inProteus mirabilis. Infect. Immun. 1999;67:2769–2775.
Li S., Yu Y., Yue Y., Zhang Z., Su K. Microbial Infection and Rheumatoid Arthritis. J. Clin. Cell. Immunol. 2013;4:174.
Ospelt C., Gay S., Klein K. Epigenetics in the pathogenesis of RA. Semin. Immunopathol. 2017;39:409–419.
Dubey, A., Yadav, P., Peeyush, , Verma, P., & Kumar, R. (2022). Investigation of Proapoptotic Potential of Ipomoea carnea Leaf Extract on Breast Cancer Cell Line. Journal of Drug Delivery and Therapeutics, 12(1), 51-55. https://doi.org/10.22270/jddt.v12i1.5172
Roshan Kumar, Purabi Saha, Priya Lokare, Kunal Datta, P. Selvakumar, & Anurag Chourasia. (2022). A Systemic Review of Ocimum sanctum (Tulsi): Morphological Characteristics, Phytoconstituents and Therapeutic Applications. International Journal for Research in Applied Sciences and Biotechnology, 9(2), 221–226. https://doi.org/10.31033/ijrasb.9.2.15
Orozco G., McAllister K., Eyre S. Genetics of rheumatoid arthritis: GWAS and beyond. Open Access Rheumatol. Res. Rev. 2011;3:31–46.
Lenz T.L., Deutsch A., Han B., Hu X., Okada Y., Eyre S., Knapp M., Zhernakova A., Huizinga T.W., Abecasis G., et al. Widespread non-additive and interaction effects within HLA loci modulate the risk of autoimmune diseases. Nat. Genet. 2015;47:1085–1090.
Zhang Q., Vignali D.A. Co-stimulatory and Co-inhibitory Pathways in Autoimmunity. Immunology. 2016;44:1034–1051.
Yap H.-Y., Tee S.Z.-Y., Wong M.M.-T., Chow S.-K., Peh S.-C., Teow S.-Y. Pathogenic Role of Immune Cells in Rheumatoid Arthritis: Implications in Clinical Treatment and Biomarker Development. Cells. 2018;7:161.
Majorczyk E., Jasek M., Ploski R., Wagner M., Kosior A., Pawlik A., Obojski A., Łuszczek W., Nowak I., Wiśniewski A., et al. Association of PTPN22 single nucleotide polymorphism with rheumatoid arthritis but not with allergic asthma. Eur. J. Hum. Genet. 2007;15:1043–1048.
Roshan Kumar, Purabi Saha, Priya Lokare, Kunal Datta, P. Selvakumar, & Anurag Chourasia. (2022). A Systemic Review of Ocimum sanctum (Tulsi): Morphological Characteristics, Phytoconstituents and Therapeutic Applications. International Journal for Research in Applied Sciences and Biotechnology, 9(2), 221–226. https://doi.org/10.31033/ijrasb.9.2.15
Saha, P., Kumar, R., Nyarko, R. O., Kahwa, I., & Owusu, P. (2021). HERBAL SECONDARY METABOLITE FOR GASTRO-PROTECTIVE ULCER ACTIVITY WITH API STRUCTURES.
Bind, A., Das, S., Singh, V. D., Kumar, R., Chourasia, A., & Saha, P. NATURAL BIOACTIVES FOR THE POTENTIAL MANAGEMENT OF GASTRIC ULCERATION. Turkish Journal of Physiotherapy and Rehabilitation, 32, 3.
Kumar, R., Saha, P., Kumar, Y., Sahana, S., Dubey, A., & Prakash, O. (2020). A REVIEW ON DIABETES MELLITUS: TYPE1 & TYPE2.
Sahana, S. (2020). Purabi saha, Roshan kumar, Pradipta das, Indranil Chatterjee, Prasit Roy, Sk Abdur Rahamat. A Review of the 2019 Corona virus (COVID-19) World Journal of Pharmacy and Pharmaceutical science, 9(9), 2367-2381.
Baka Z., Buzás E., Nagy G. Rheumatoid arthritis and smoking: Putting the pieces together. Arthritis Res. Ther. 2009;11:238.
Van Drongelen V., Holoshitz J. Human Leukocyte Antigen–Disease Associations in Rheumatoid Arthritis. Rheum. Dis. Clin. North. Am. 2017;43:363–376.
Viatte S., Plant D., Han B., Fu B., Yarwood A., Thomson W., Symmons D., Worthington J., Young A., Hyrich K.L., et al. Association of HLA-DRB1 haplotypes with rheumatoid arthritis severity, mortality, and treatment response. JAMA. 2015;313:1645–1656.
Chen J., Li J., Gao H., Wang C., Luo J., Lv Z., Li X. Comprehensive Evaluation of Different T-Helper Cell Subsets Differentiation and Function in Rheumatoid Arthritis. J. Biomed. Biotechnol. 2012;2012:1–6.
Coutant F., Miossec P. Altered dendritic cell functions in autoimmune diseases: Distinct and overlapping profiles. Nat. Rev. Rheumatol. 2016;12:703–715.
Jongbloed S.L., Lebre M.C., Fraser A.R., Gracie J.A., Sturrock R.D., Tak P.-P., McInnes I. Enumeration and phenotypical analysis of distinct dendritic cell subsets in psoriatic arthritis and rheumatoid arthritis. Arthritis Res. Ther. 2005;8:R15.
Page G., Miossec P. Paired synovium and lymph nodes from rheumatoid arthritis patients differ in dendritic cell and chemokine expression. J. Pathol. 2004;204:28–38.
Segura E., Touzot M., Bohineust A., Cappuccio A., Chiocchia G., Hosmalin A., Dalod M., Soumelis V., Amigorena S. Human Inflammatory Dendritic Cells Induce Th17 Cell Differentiation. Immunity. 2013;38:336–348.
Lebre M.C., Jongbloed S.L., Tas S.W., Smeets T.J., McInnes I., Tak P.P. Rheumatoid Arthritis Synovium Contains Two Subsets of CD83−DC-LAMP− Dendritic Cells with Distinct Cytokine Profiles. Am. J. Pathol. 2008;172:940–950.
Tournadre A., Lenief V., Miossec P. Immature muscle precursors are a source of interferon-β in myositis: Role of Toll-like receptor 3 activation and contribution to HLA class I up-regulation. Arthritis Rheum. 2012;64:533–541.
Castañeda-Delgado J.E., Bastian Y., Macias-Segura N., Santiago-Algarra D., Castillo-Ortiz J.D., Alemán-Navarro A.L., Martínez-Tejada P., Enciso-Moreno L., Lira Y.G.-D., Olguín-Calderón D., et al. Type I Interferon Gene Response Is Increased in Early and Established Rheumatoid Arthritis and Correlates with Autoantibody Production. Front. Immunol. 2017;8:279.
Cooles F.A., Anderson A., Lendrem D., Norris J., Pratt A., Hilkens C.M.U., Isaacs J.D. The interferon gene signature is increased in patients with early treatment-naive rheumatoid arthritis and predicts a poorer response to initial therapy. J. Allergy Clin. Immunol. 2018;141:445–448.
Page G., Lebecque S., Miossec P. Anatomic Localization of Immature and Mature Dendritic Cells in an Ectopic Lymphoid Organ: Correlation with Selective Chemokine Expression in Rheumatoid Synovium. J. Immunol. 2002;168:5333–5341.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 International Journal for Research in Applied Sciences and Biotechnology
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
editor@ijrasb.com 